2023-508998-85-00CompletedPhase 1
A study to find a suitable dose of BI 765883 and to test whether it helps people with advanced pancreatic cancer when taken alone or together with chemotherapy
Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 Dec 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 28 Mar 2024
- Start date
- 28 Jan 2025
- Lead sponsor
- Boehringer Ingelheim International GmbH
- Diseases
- Pancreatic cancer
- EU CT number
- 2023-508998-85-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 48
- 12 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (12)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UZ Leuven | Leuven | Belgium | Completed |
| Cliniques Universitaires Saint-Luc | Sint-Lambrechts-Woluwe | Belgium | Completed |
| Universitaetsklinikum Essen (AoR) | Essen | Germany | Completed |
| University Medical Center Hamburg-Eppendorf | Hamburg | Germany | Completed |
| Universitaetsklinikum Heidelberg AöR | Heidelberg | Germany | Completed |
| Klinikum der Universitaet Muenchen AöR | Munich | Germany | Completed |
| Hospital Clinic de Barcelona | Barcelona | Spain | Completed |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Completed |
| Hospital Universitario Ramón y Cajal | Madrid | Spain | Completed |
| Centre Leon Berard | Lyon | France | Completed |
| Centre De Lutte Contre Le Cancer Eugene Marquis | Rennes Cedex | France | Completed |
| Institut Gustave Roussy | Villejuif | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.